Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Fortress Biotech, Inc. Insider Profile
11 Followers
Fortress Biotech, Inc., Ten Percent Owner at Avenue Therapeutics, holds 3.74M shares in Checkpoint Therapeutics (Ticker: CKPT), holds 2.50M shares in Mustang Bio (Ticker: MBIO), holds 3.86M shares in Journey Medical Corp (Ticker: DERM).
Fortress Biotech, Inc. has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Fortress Biotech, Inc. holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Sep 12, 2023 - Sep 12, 2024
Return:-95.30%
The most profitable trade made by Fortress Biotech, Inc.
Fortress Biotech, Inc.'s Trading History
Avenue Therapeutics
Apr 17, 2024
Ten Percent Owner
Uninformative Buy
―
$7.41M
Checkpoint Therapeutics
Oct 01, 2024
Ten Percent Owner
Uninformative Buy
―
$9.86M
Mustang Bio
Jun 28, 2024
Ten Percent Owner
Uninformative Buy
―
$545.65K
Journey Medical Corp
May 31, 2024
Ten Percent Owner
Uninformative Sell
―
$22.24M
List of latest transactions for each holding click on a transaction to see Fortress Biotech, Inc.'s performance on stock
You May Also Like
Fortress Biotech, Inc. insider profile FAQ
What is the percentage of profitable transactions made by Fortress Biotech, Inc.?
The percentage of profitable transactions made by Fortress Biotech, Inc. is ―.
What is the average return per transaction made by Fortress Biotech, Inc.?
The average return per transaction made by Fortress Biotech, Inc. is ―.
What stocks does Fortress Biotech, Inc. hold?
Fortress Biotech, Inc. holds: ATXI, CKPT, MBIO, DERM stocks.
What was Fortress Biotech, Inc.’s latest transaction?
Fortress Biotech, Inc. latest transaction was an Uninformative Buy of ―.
What was Fortress Biotech, Inc.'s most profitable transaction?
Fortress Biotech, Inc.’s most profitable transaction was an Informative Buy of ATXI stock on September 12, 2023. The return on the trade was -95.30%.
What is Fortress Biotech, Inc.'s role in Avenue Therapeutics?
Fortress Biotech, Inc.'s role in Avenue Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.